Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Antengene Corporation Limited ( (HK:6996) ) is now available.
Antengene Corporation Limited has announced its intention to conduct an on-market share repurchase, as approved by its board of directors. The company plans to repurchase up to 67,944,663 shares, representing 10% of its issued shares, with a maximum aggregate price of HK$40 million. This strategic move is aimed at demonstrating confidence in its business outlook and enhancing shareholder value, while maintaining a solid financial position. The implementation of the share repurchase will depend on market conditions and the board’s discretion, with no assurance on the timing or quantity of shares to be repurchased.
The most recent analyst rating on (HK:6996) stock is a Hold with a HK$2.99 price target. To see the full list of analyst forecasts on Antengene Corporation Limited stock, see the HK:6996 Stock Forecast page.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapeutics for cancer and other life-threatening diseases. The company is listed on the Hong Kong Stock Exchange under the stock code 6996.
YTD Price Performance: 880.0%
Average Trading Volume: 6,035,707
Technical Sentiment Signal: Buy
Current Market Cap: HK$4.04B
For detailed information about 6996 stock, go to TipRanks’ Stock Analysis page.